Citation Tools

PDF

Original article
Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal

Download to a citation manager

Cite this article as:
Ikenaga N, Peng Z, Vaid KA, et al
Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal